MTM Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Sell
1,857
-61
-3% -$10.5K 0.15% 68
2026
Q1
$314K Sell
1,918
-61
-3% -$10.4K 0.15% 69
2025
Q4
$324K Buy
1,979
+1
+0.1% +$162 0.15% 67
2025
Q3
$277K Hold
1,978
0.14% 72
2025
Q2
$243K Sell
1,978
-108
-5% -$13.3K 0.13% 72
2025
Q1
$259K Sell
2,086
-51
-2% -$6.92K 0.15% 67
2024
Q4
$275K Sell
2,137
-146
-6% -$20.5K 0.16% 64
2024
Q3
$324K Sell
2,283
-24
-1% -$3.47K 0.2% 57
2024
Q2
$308K Sell
2,307
-75
-3% -$10K 0.2% 56
2024
Q1
$319K Sell
2,382
-141
-6% -$19.3K 0.21% 51
2023
Q4
$335K Sell
2,523
-73
-3% -$8.91K 0.24% 41
2023
Q3
$310K Sell
2,596
-203
-7% -$25.8K 0.26% 41
2023
Q2
$348K Buy
2,799
+17
+0.6% +$2.21K 0.29% 39
2023
Q1
$352K Buy
2,782
+25
+0.9% +$3.27K 0.31% 35
2022
Q4
$354K Hold
2,757
0.31% 37
2022
Q3
$315K Sell
2,757
-517
-16% -$64.2K 0.29% 35
2022
Q2
$378K Sell
3,274
-227
-6% -$26.9K 0.33% 36
2022
Q1
$448K Buy
+3,501
New +$456K 0.47% 32

Other funds holding IBB

MTM Financial Group's IBB Position: Q2 2026 in Review

MTM Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 3.2% in Q2 2026, selling an estimated $10.5K and leaving 1,857 shares worth $353K. The position accounts for 0.15% of the portfolio, ranked #68.

MTM Financial Group first reported a position in IBB in Q1 2022 and has held it in 18 quarters since. The position peaked at $448K in Q1 2022. 953 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • MTM Financial Group held 1,857 shares of iShares Biotechnology ETF worth $353K as of Q2 2026.
  • MTM Financial Group sold 61 iShares Biotechnology ETF shares in Q2 2026, an estimated $10.5K.
  • iShares Biotechnology ETF made up 0.15% of MTM Financial Group's portfolio in Q2 2026, its #68 holding.
  • MTM Financial Group first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
  • MTM Financial Group's iShares Biotechnology ETF position peaked at $448K in Q1 2022.
  • 953 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on MTM Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.